ArticleFrontiers in health services2026
Access to specialist ataxia centres in Europe: cross-sectional surveys in the United Kingdom, Italy, and Germany.
Article in Frontiers in health services, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Progressive ataxias are a diverse and rare group of neurodegenerative conditions characterised by unsteadiness, incoordination and slurred speech. Additional neurological features and pathology outside the central nervous system may also be present. Aim: This study explored factors associated with referral to SACs or discontinued access. Methods: Responses to cross-sectional surveys conducted separately in three European countries were collated. The national surveys were conducted at different times and the question format evolved, requiring responses to be harmonised. The 550 individual responses were examined for associations between SAC access and respondent characteristics. Results: Respondents with a genetic diagnosis were observed to have greater representation in SACs in Italy and Germany than in the UK, with this contrast being most prominent with a diagnosis of Friedreich's ataxia. Respondents with Idiopathic Cerebellar Ataxia also had significantly lower proportion of referrals in the UK relative to Germany and Italy. Fewer reported comorbidities, being in employment, and shorter travel time to SACs were associated with reported SAC attendance or referral. Increasing mobility impairment was associated with reported discontinuation of SAC attendance. No statistically significant associations were observed between SAC attendance and referral source, time since diagnosis, or reported impact of ataxia on daily living. Conclusions: Statistically significant differences between SAC and non-SAC respondent cohorts were observed, as well as variations in SAC access between countries. These findings highlight factors that may be relevant to SAC utilisation. The results suggest potential areas for further investigation, including strategies to support access, such as telehealth, and may inform the design of future multinational studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.